These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 9402011

  • 1. Non-glycosaminoglycan bearing domains of perlecan and aggrecan influence the utilization of sites for heparan and chondroitin sulfate synthesis.
    Doege K, Chen X, Cornuet PK, Hassell J.
    Matrix Biol; 1997 Oct; 16(4):211-21. PubMed ID: 9402011
    [Abstract] [Full Text] [Related]

  • 2. Identification of sites in domain I of perlecan that regulate heparan sulfate synthesis.
    Dolan M, Horchar T, Rigatti B, Hassell JR.
    J Biol Chem; 1997 Feb 14; 272(7):4316-22. PubMed ID: 9020150
    [Abstract] [Full Text] [Related]

  • 3. Formation of heparan sulfate or chondroitin/dermatan sulfate on recombinant domain I of mouse perlecan expressed in Chinese hamster ovary cells.
    Kokenyesi R, Silbert JE.
    Biochem Biophys Res Commun; 1995 Jun 06; 211(1):262-7. PubMed ID: 7779094
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms underlying preferential assembly of heparan sulfate on glypican-1.
    Chen RL, Lander AD.
    J Biol Chem; 2001 Mar 09; 276(10):7507-17. PubMed ID: 11106655
    [Abstract] [Full Text] [Related]

  • 5. Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain I.
    French MM, Gomes RR, Timpl R, Höök M, Czymmek K, Farach-Carson MC, Carson DD.
    J Bone Miner Res; 2002 Jan 09; 17(1):48-55. PubMed ID: 11771669
    [Abstract] [Full Text] [Related]

  • 6. Localization of glycosaminoglycan substitution sites on domain V of mouse perlecan.
    Tapanadechopone P, Hassell JR, Rigatti B, Couchman JR.
    Biochem Biophys Res Commun; 1999 Nov 30; 265(3):680-90. PubMed ID: 10600481
    [Abstract] [Full Text] [Related]

  • 7. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
    Kosir MA, Quinn CC, Wang W, Tromp G.
    J Surg Res; 2000 Jul 30; 92(1):45-52. PubMed ID: 10864481
    [Abstract] [Full Text] [Related]

  • 8. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan.
    Engbring JA, Hoffman MP, Karmand AJ, Kleinman HK.
    Cancer Res; 2002 Jun 15; 62(12):3549-54. PubMed ID: 12068003
    [Abstract] [Full Text] [Related]

  • 9. Platelet Factor 4 Binds to Vascular Proteoglycans and Controls Both Growth Factor Activities and Platelet Activation.
    Lord MS, Cheng B, Farrugia BL, McCarthy S, Whitelock JM.
    J Biol Chem; 2017 Mar 10; 292(10):4054-4063. PubMed ID: 28115521
    [Abstract] [Full Text] [Related]

  • 10. Role of the C-terminal G3 domain in sorting and secretion of aggrecan core protein and ubiquitin-mediated degradation of accumulated mutant precursors.
    Domowicz MS, Pirok EW, Novak TE, Schwartz NB.
    J Biol Chem; 2000 Nov 10; 275(45):35098-105. PubMed ID: 11063750
    [Abstract] [Full Text] [Related]

  • 11. The folded modules of aggrecan G3 domain exert two separable functions in glycosaminoglycan modification and product secretion.
    Chen L, Wu Y, Lee V, Kiani C, Adams ME, Yao Y, Yang BB.
    J Biol Chem; 2002 Jan 25; 277(4):2657-65. PubMed ID: 11714693
    [Abstract] [Full Text] [Related]

  • 12. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
    Castillo GM, Cummings JA, Yang W, Judge ME, Sheardown MJ, Rimvall K, Hansen JB, Snow AD.
    Diabetes; 1998 Apr 25; 47(4):612-20. PubMed ID: 9568695
    [Abstract] [Full Text] [Related]

  • 13. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
    Snow AD, Kinsella MG, Parks E, Sekiguchi RT, Miller JD, Kimata K, Wight TN.
    Arch Biochem Biophys; 1995 Jun 20; 320(1):84-95. PubMed ID: 7793988
    [Abstract] [Full Text] [Related]

  • 14. Roles of aggrecan domains in biosynthesis, modification by glycosaminoglycans and product secretion.
    Kiani C, Lee V, Cao L, Chen L, Wu Y, Zhang Y, Adams ME, Yang BB.
    Biochem J; 2001 Feb 15; 354(Pt 1):199-207. PubMed ID: 11171095
    [Abstract] [Full Text] [Related]

  • 15. Perlecan is a component of cartilage matrix and promotes chondrocyte attachment.
    SundarRaj N, Fite D, Ledbetter S, Chakravarti S, Hassell JR.
    J Cell Sci; 1995 Jul 15; 108 ( Pt 7)():2663-72. PubMed ID: 7593307
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chondroitin sulfate perlecan enhances collagen fibril formation. Implications for perlecan chondrodysplasias.
    Kvist AJ, Johnson AE, Mörgelin M, Gustafsson E, Bengtsson E, Lindblom K, Aszódi A, Fässler R, Sasaki T, Timpl R, Aspberg A.
    J Biol Chem; 2006 Nov 03; 281(44):33127-39. PubMed ID: 16956876
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The role of vascular-derived perlecan in modulating cell adhesion, proliferation and growth factor signaling.
    Lord MS, Chuang CY, Melrose J, Davies MJ, Iozzo RV, Whitelock JM.
    Matrix Biol; 2014 Apr 03; 35():112-22. PubMed ID: 24509440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.